Anti-Obesity Activity of Euptelea Pleiosperma Ethanol Extract |
Park, Jung Ae
(Blue-Bio Industry Regional Innovation Center, Dong-Eui University)
Jin, Kyong-Suk (Blue-Bio Industry Regional Innovation Center, Dong-Eui University) Kwon, Hyun Ju (Blue-Bio Industry Regional Innovation Center, Dong-Eui University) Kim, Byung Woo (Blue-Bio Industry Regional Innovation Center, Dong-Eui University) |
1 | Chadt A, Scherneck S, Joost HG, Al-Hasani H. 2000. Molecular links between Obesity and Diabetes: "Diabesity". |
2 | de la Garza AL, Milagro FI, Boque N, Campion J, Martinez JA. 2011. Natural inhibitors of pancreatic lipase as new players in obesity treatment. Planta Med. 77: 773-785. DOI |
3 | Fock KM, Khoo J. 2013. Diet and exercise in management of obesity and overweight. J. Gastroenterol. Hepatol. 28(Suppl. 4): 59-63. DOI |
4 | Guo L, Li X, Tang QQ. 2015. Transcriptional regulation of adipocyte differentiation: a central role for CCAAT/enhancer-binding protein (C/EBP) beta. J. Biol. Chem. 290: 755-761. DOI |
5 | Haslam D. 2007. Obesity: a medical history. Obes. Rev. 8(Suppl. 1): 31-36. DOI |
6 | Jin KS, Park JA, Lee JY, Kang JS, Kwon HJ, Kim BW. 2014. Anti-oxidative and anti-inflammatory activities of Euptelea pleiosperma ethanol extract. Korean J. Microbiol. Biotechnol. 42: 170-176. DOI |
7 | Joo JK, Lee KS. 2014. Pharmacotherapy for obesity. J. Menopausal Med. 20: 90-96. DOI |
8 | Kakkar AK, Dahiya N. 2015. Drug treatment of obesity: current status and future prospects. Eur. J. Int. Med. 26: 89-94. DOI |
9 | Lane MD, Tang QQ, Jiang MS. 1999. Role of the CCAAT enhancer binding proteins (C/EBPs) in adipocyte differentiation. Biochem. Biophys. Res. Commun. 266: 677-683. DOI |
10 | Liu F, Kim J, Li Y, Liu X, Li J, Chen X. 2001. An extract of Lagerstroemia speciosa L. has insulin-like glucose uptake-stimulatory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells. J. Nutr. 131: 2242-2247. DOI |
11 | Ali AT, Hochfeld WE, Myburgh R, Pepper MS. 2013. Adipocyte and adipogenesis. Eur. J. Cell Biol. 92: 229-236. DOI |
12 | Avram MM, Avram AS, James WD. 2007. Subcutaneous fat in normal and diseased states 3. Adipogenesis: from stem cell to fat cell. J. Am. Acad. Dermatol. 56: 472-492. DOI |
13 | Berry R, Jeffery E, Rodeheffer MS. 2014. Weighing in on adipocyte precursors. Cell Metab. 19: 8-20. DOI |
14 | Bray GA. 2007. Medical therapy for obesity-current status and future hopes. Med. Clin. North Am. 91: 1225-1253. DOI |
15 | Cao Z, Umek RM, McKnight SL. 1991. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 5: 1538-1552. DOI |
16 | Manulu MS, Sutanegara IN. 2006. Pathogenesis and pharmacologic treatment of obesity: the role of energy regulatory mechanism. Acta Med. Indones. 38: 42-50. |
17 | Ntambi JM, Young-Cheul K. 2000. Adipocyte differentiation and gene expression. J. Nutr. 130: 3122S-3126S. DOI |
18 | Rosen ED, Hsu CH, Wang X, Sakai S, Freeman MW, Gonzalez FJ, et al. 2002. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev. 16: 22-26. DOI |
19 | Sorisky A. 1999. From preadipocyte to adipocyte: differentiation-directed signals of insulin from the cell surface to the nucleus. Crit. Rev. Clin. Lab. Sci. 36: 1-34. DOI |
20 | World Health Organization 2015. Obesity and overweight. Fact sheet . Available at: http://www.who.int/mediacentre/factsheets/fs311/en/. Accessed 28 August 2015. |
21 | Zhang WL, Zhu L, Jiang JG. 2014. Active ingredients from natural botanicals in the treatment of obesity. Obes. Rev. 15: 957-967. DOI |